| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Revenue | $811.0M | -9.2% |
| Cost of Revenue | $554.1M | -8.1% |
| Gross Profit | $256.9M | -11.5% |
| R&D Expense | $87.0M | +2.6% |
| SG&A Expense | $137.8M | +7.3% |
| Operating Income | $32.1M | -58.4% |
| Pre-tax Income | $5.0M | -84.0% |
| Income Tax | $52.2M | +400.0% |
| Net Income | -$47.7M |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Cash & Equivalents | $168.7M | +10.6% |
| Short-term Investments | $31.8M | -23.0% |
| Accounts Receivable | $157.7M | -3.6% |
| Inventory | $264.8M | -4.6% |
| Current Assets | $649.9M | -1.3% |
| Total Assets | $1.22B | -2.6% |
| Current Liabilities | $195.9M | +20.3% |
| Line Item | 2024-09-27 | Y/Y |
|---|---|---|
| Operating Cash Flow | $47.3M | -56.4% |
| Capital Expenditures | $26.9M | +30.0% |
| Investing Cash Flow | -$27.5M | +38.8% |
| Financing Cash Flow | -$3.3M | -1550.0% |
| Free Cash Flow | $20.4M | -76.7% |
| -199.0% |
| EPS (Basic) | -$1.17 | -197.5% |
| EPS (Diluted) | -$1.17 | -208.3% |
| Long-term Debt |
| $443.4M |
| +0.2% |
| Total Liabilities | $667.8M | -0.1% |
| Stockholders' Equity | $535.1M | -5.7% |